Updates

Author Details

Joe Pierce

May 13, 2021May 13, 2021
$10.7M NIH Grant to Fund Genetic Research in Alzheimer’s

A $10.7-million grant to investigate the genetic underpinnings of Alzheimer’s disease has been awarded to the University of Pittsburgh Graduate School of Public Health and ... Read more
May 10, 2021May 10, 2021
Insufficient Evidence of Aducanumab Efficacy, ICER Draft Report Finds

A draft report from the Institute for Clinical and Economic Review, known as ICER, found that there is insufficient evidence to determine whether the investigational ... Read more
May 6, 2021May 6, 2021
Longeveron’s Stem Cell Therapy Shows Potential in Phase 1 Trial

Longeveron’s Lomecel-B, an investigational bone marrow-derived medicinal signaling cell (MSC), showed an ability to slow cognitive decline and the loss of daily life abilities in patients with ... Read more
May 3, 2021April 29, 2021
By Getting Involved, You Can Help Find a Cure for Alzheimer’s

Dementia is potentially preventable in more than a third of reported cases, according to the Alzheimer’s Association. This is encouraging, and also surprising. It is ... Read more
May 3, 2021May 3, 2021
FDA Places Gene Therapy LX1001 on Fast Track

LX1001, a gene therapy for Alzheimer’s disease being developed by Lexeo Therapeutics, has been granted fast track designation by the U.S. Food and Drug Administration ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Author Details

Joe Pierce

Thanks! Please check your email for a confirmation email.

November 8, 2017November 8, 2017

Anavex ‘Cautiously Optimistic’ After Noting Cognitive Improvement in Alzheimer’s Treatment

News

Anavex Life Sciences says its Alzheimer’s drug candidate Anavex 2-73 may have a role in treating the disease. Data from a long-term extension trial, although small, indicated that the therapy improved cognitive and functional measures in patients. According to data presented ... Read more

$10.7M NIH Grant to Fund Genetic Research in Alzheimer’s

Insufficient Evidence of Aducanumab Efficacy, ICER Draft Report Finds

Longeveron’s Stem Cell Therapy Shows Potential in Phase 1 Trial

By Getting Involved, You Can Help Find a Cure for Alzheimer’s

FDA Places Gene Therapy LX1001 on Fast Track

#AANAM – Nuplazid Not Linked to Side Effects Common to Antipsychotics

Tough Love Helps Protect Loved Ones with Alzheimer’s

Movement Gets Youth Involved in Alzheimer’s Advocacy, Education

#AANAM – EMBARK Trial to Again Test Safety, Efficacy of Aducanumab

#AANAM – Lecanemab Safely, Quickly Lowers Amyloid Clumps in Trial

These Signs May Indicate Early Dementia or Alzheimer’s Disease

Subscribe to our mailing list

Greater Support for Dementia Patients Needed Across Europe, Report Says

Safety Seen in Trial of Oral Treatment, Anavex 2-73, for Early Alzheimer’s

Alzheimer’s Disease, Clinical Trials, and You

GV1001 Treatment Shows Promise for Moderate to Severe Alzheimer’s

Effects of War, Dementia Animated in Short Film ‘Winter Memories’

Agent Orange Exposure Increases Risk of Dementia in Vietnam Veterans

FDA Rejects Nuplazid to Treat Dementia-related Psychosis

Montana Residents May Order Free Children’s Storybook About Alzheimer’s

Alzheimer’s Organization Delivers Grim Statistics in Annual Report

Sargramostim, Immune System Activator, May Aid Cognition, Small Trial Finds

Donanemab Shows Potential for Early Alzheimer’s in Phase 2 Trial

Sulbutamol, for Respiratory Ills, Seen to Improve Blood Flow in Brain

Neurostimulation Slows Decline in Mild-to-moderate Alzheimer’s, Trial Finds

Flu and Pneumonia Vaccines Lessen Risk of Alzheimer’s Disease

Noninvasive Genetic Risk Test for Alzheimer’s Coming to EU, US

FDA Finds ‘Deficiencies’ in Request for Nuplazid to Treat Dementia-Related Psychosis

Caregivers Must Protect Seniors from Scammers, Especially During Tax Season

Racial Discrimination Can Be Barrier in Healthcare, Surveys Find

Pivotal Phase 3 Trials of Oral Simufilam Planned for Year’s End

Phase 1 Trial to Test BDNF Gene Therapy in Alzheimer’s Patients

Grants of $4.6M to Support Trials of Cancer Therapy in Early Alzheimer’s

Dementia Patients Have a Greater Risk of Contracting COVID-19

UsAgainstAlzheimer’s Calls for $289M Hike in Federal Funds for Research

HFC to Host CareCon, Virtual Event for Caregivers

Remaining in the Moment Is the Best Strategy for Alzheimer’s Caregivers

Oral Simufilam Found to Improve Cognition, Behavior After 6 Months’ Use

Alzheimer’s Association Webinar Tackles Care Disparities for Blacks in US

Seniors Lack Easy Access to Important Health Information

Adira Foundation Arises From Life-altering Accident to Help Those With Chronic Ills

Phase 3 Trial of Therapy for Inflammation, Insulin-sensitivity in Alzheimer’s to Open

Troriluzole Fails to Ease Cognitive Impairments in Phase 2/3 Trial